Cargando…

Decision Analytic Modeling for Global Clinical Trial Planning: A Case for HIV-Positive Patients at High Risk for Mycobacterium tuberculosis Sepsis in Uganda

Sepsis is a significant cause of mortality among people living with human immunodeficiency virus (HIV) in sub-Saharan Africa. In the planning period prior to the start of a large multi-country clinical trial studying the efficacy of the immediate empiric addition of anti-tuberculosis therapy to stan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keim-Malpass, Jessica, Heysell, Scott K., Thomas, Tania A., Lobo, Jennifer M., Mpagama, Stellah G., Muzoora, Conrad, Moore, Christopher C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049353/ https://www.ncbi.nlm.nih.gov/pubmed/36981950 http://dx.doi.org/10.3390/ijerph20065041

Ejemplares similares

Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial
por: Said, Bibie, et al.
Publicado: (2022)

Multiple Pathogens Contribute to Human Immunodeficiency Virus-Related Sepsis in Addition to Mycobacterium tuberculosis: A Prospective Cohort in Tanzania
por: Tsere, Donatus Bonphace, et al.
Publicado: (2022)

Coinfection of COVID-19 and Tuberculosis in Uganda
por: Nuwagira, Edwin, et al.
Publicado: (2023)

Evaluation of cytokines in peripheral blood mononuclear cell supernatants for the diagnosis of tuberculosis
por: Sariko, Margaretha, et al.
Publicado: (2018)

Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania
por: Ebers, Andrew, et al.
Publicado: (2017)

Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis
por: Sariko, Margaretha, et al.
Publicado: (2017)

Diagnostic Opportunities for Optimizing Management of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania
por: Mpagama, Stellah G
Publicado: (2018)

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
por: Mpagama, Stellah G, et al.
Publicado: (2013)

Pharmacodynamic Biomarkers for Quantifying the Mycobacterial Effect of High Doses of Rifampin in Patients with Rifampin-susceptible Pulmonary Tuberculosis
por: Said, Bibie N, et al.
Publicado: (2021)

Beyond prediction: Off‐target uses of artificial intelligence‐based predictive analytics in a learning health system
por: Keim‐Malpass, Jessica, et al.
Publicado: (2022)

TB or not TB? Definitive determination of species within the M ycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug‐resistant tuberculosis
por: Mbelele, Peter M., et al.
Publicado: (2021)

Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
por: Mpagama, Stellah G., et al.
Publicado: (2020)

Meta-Narrative Review of Molecular Methods for Diagnosis and Monitoring of Multidrug-Resistant Tuberculosis Treatment in Adults
por: Mbelele, Peter M., et al.
Publicado: (2018)

Comparison of Overnight Pooled and Standard Sputum Collection Method for Patients with Suspected Pulmonary Tuberculosis in Northern Tanzania
por: Mpagama, Stellah G., et al.
Publicado: (2012)

Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation
por: Mpagama, Stellah G., et al.
Publicado: (2019)

Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis
por: Sidamo, Temesgen, et al.
Publicado: (2022)

Dynamic Transitions of Pediatric Sepsis: A Markov Chain Analysis
por: Kausch, Sherry L., et al.
Publicado: (2021)

Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2022)

Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania
por: Juma, Saumu Pazia, et al.
Publicado: (2019)

Improvement in Plasma Drug Activity during the Early Treatment Interval among Tanzanian Patients with Multidrug-Resistant Tuberculosis
por: Ndusilo, Norah D., et al.
Publicado: (2015)

Diagnosis and Interim Treatment Outcomes from the First Cohort of Multidrug-Resistant Tuberculosis Patients in Tanzania
por: Mpagama, Stellah G., et al.
Publicado: (2013)

Pulmonary Tuberculosis and Mycobacterium bovis, Uganda
por: Byarugaba, Frederick, et al.
Publicado: (2009)

Time to decision in sepsis
por: Ferrer, Ricard, et al.
Publicado: (2022)

Gridlock from Diagnosis to Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania: Illuminating Potential Factors for Possible Intervention
por: Liyoyo, Alphonce A, et al.
Publicado: (2017)

Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis
por: Operario, Darwin J., et al.
Publicado: (2017)

Nursing and precision predictive analytics monitoring in the acute and intensive care setting: An emerging role for responding to COVID-19 and beyond
por: Keim-Malpass, Jessica, et al.
Publicado: (2021)

Correction: Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis
por: Operario, Darwin J., et al.
Publicado: (2017)

Protocol for establishing an Adaptive Diseases control Expert Programme in Tanzania (ADEPT) for integrating care of communicable and non-communicable diseases using tuberculosis and diabetes as a case study
por: Mpagama, Stellah G, et al.
Publicado: (2021)

Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong’oto infectious diseases hospital in Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2017)

Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania
por: Katale, Bugwesa Z., et al.
Publicado: (2020)

Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study
por: Musiimenta, Angella, et al.
Publicado: (2019)

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study
por: Van Aartsen, Daniel, et al.
Publicado: (2022)

A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva
por: Alffenaar, Jan-Willem C, et al.
Publicado: (2020)

Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy
por: Ahmed, Mohamed I. M., et al.
Publicado: (2018)

Silicosis, tuberculosis and silica exposure among artisanal and small-scale miners: A systematic review and modelling paper
por: Howlett, Patrick, et al.
Publicado: (2023)

Clinical-demographic markers for improving diabetes mellitus diagnosis in people with tuberculosis in Tanzania
por: Byashalira, Kenneth Cleophace, et al.
Publicado: (2022)

Individual illness dynamics: An analysis of children with sepsis admitted to the pediatric intensive care unit
por: Kausch, Sherry L., et al.
Publicado: (2022)

Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania
por: Mpagama, Stellah G., et al.
Publicado: (2023)

Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_masjl8pb1b8cgu115tq2ue15sr